- Home
- ZBAO vs ATRA Comparison
ZBAO vs ATRA Comparison
Compare ZBAO & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBAO
- ATRA
- Stock Information
- Founded
- ZBAO 2015
- ATRA 2012
- Country
- ZBAO China
- ATRA United States
- Employees
- ZBAO N/A
- ATRA N/A
- Industry
- ZBAO
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZBAO
- ATRA Health Care
- Exchange
- ZBAO NYSE
- ATRA Nasdaq
- Market Cap
- ZBAO 36.2M
- ATRA 32.4M
- IPO Year
- ZBAO 2024
- ATRA 2014
- Fundamental
- Price
- ZBAO $1.31
- ATRA $6.90
- Analyst Decision
- ZBAO
- ATRA Buy
- Analyst Count
- ZBAO 0
- ATRA 5
- Target Price
- ZBAO N/A
- ATRA $17.75
- AVG Volume (30 Days)
- ZBAO 498.7K
- ATRA 48.6K
- Earning Date
- ZBAO 04-15-2025
- ATRA 05-08-2025
- Dividend Yield
- ZBAO N/A
- ATRA N/A
- EPS Growth
- ZBAO N/A
- ATRA N/A
- EPS
- ZBAO 0.09
- ATRA N/A
- Revenue
- ZBAO $33,673,520.00
- ATRA $128,940,000.00
- Revenue This Year
- ZBAO $65.08
- ATRA N/A
- Revenue Next Year
- ZBAO $34.27
- ATRA N/A
- P/E Ratio
- ZBAO $11.61
- ATRA N/A
- Revenue Growth
- ZBAO 82.66
- ATRA 1404.02
- 52 Week Low
- ZBAO $0.85
- ATRA $5.01
- 52 Week High
- ZBAO $5.70
- ATRA $19.00
- Technical
- Relative Strength Index (RSI)
- ZBAO N/A
- ATRA 57.45
- Support Level
- ZBAO N/A
- ATRA $5.62
- Resistance Level
- ZBAO N/A
- ATRA $6.11
- Average True Range (ATR)
- ZBAO 0.00
- ATRA 0.59
- MACD
- ZBAO 0.00
- ATRA 0.18
- Stochastic Oscillator
- ZBAO 0.00
- ATRA 88.76
About ZBAO ZHIBAO TECHNOLOGY INC
Zhibao Technology Inc is a insurance technology company engaged in providing digital insurance brokerage services in China. 2B2C digital embedded insurance is their business model which is pioneered in China. It provides customized digital insurance solutions for B-side channels (covering a wide range of industries and organizations, including but not limited to Internet platforms, large and medium-sized enterprises, and government agencies, etc.), embedding them into the channel's existing business matrix, and providing the channel with Provide digital insurance brokerage services to C-end customers.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).